A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children

F Priddy, S Chalkias, B Essink, J Whatley… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Introduction Vaccination against SARS-CoV-2 is an integral pillar of the public
health approach to COVID-19. With the emergence of variants of concern that increase …

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19

SM Iqbal, AM Rosen, D Edwards, A Bolio… - Frontiers in Public …, 2024 - frontiersin.org
The messenger RNA (mRNA) platform emerged at the forefront of vaccine development
during the COVID-19 pandemic, with two mRNA COVID-19 vaccines being among the first …

COVID-19 modified mRNA “vaccines”: Lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, Part 2

MN Mead, S Seneff, J Rose, R Wolfinger… - International Journal of …, 2024 - ijvtpr.com
The COVID-19 modified mRNA (modmRNA) lipid nanoparticle-based “vaccines” are not
classical antigen-based vaccines but instead prodrugs informed by gene therapy …

A descriptive review on the real-world impact of Moderna, inc. COVID-19 vaccines

M Bausch-Jurken, RS Dawson, F Ceddia… - Expert Review of …, 2024 - Taylor & Francis
Introduction Since the original COVID-19 vaccines were developed, abundant clinical trial
and real-world evidence evaluating the efficacy, effectiveness, and safety of COVID-19 …

Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A …

J Sáez-Peñataro, G Calvo, J Bascuas, MM Mosquera… - Vaccines, 2024 - mdpi.com
Enhancing our comprehension of mRNA vaccines may facilitate the future design of novel
vaccines aimed at augmenting immune protection while minimising reactogenic responses …